New insights on acute expansion and longitudinal elongation of bioresorbable vascular scaffolds in vivo and at bench test: A note of caution on reliance to compliance charts and nominal length

2014 ◽  
Vol 85 (4) ◽  
pp. E99-E107 ◽  
Author(s):  
Guilherme F. Attizzani ◽  
Yohei Ohno ◽  
Davide Capodanno ◽  
Bruno Francaviglia ◽  
Carmelo Grasso ◽  
...  
Keyword(s):  
Bench Test ◽  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds

scholarly journals Provisional T-Stenting With Bioresorbable Vascular Scaffolds In Vivo

2015 ◽  
Vol 8 (4) ◽  
pp. 635-637 ◽  
Author(s):  
Toru Naganuma ◽  
Hisaaki Ishiguro ◽  
Kensuke Takagi ◽  
Yusuke Fujino ◽  
Satoru Mitomo ◽  
...  
Keyword(s):  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds

Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: Insights from the ABSORB and SPIRIT trials

2011 ◽  
Vol 79 (2) ◽  
pp. 219-228 ◽  
Author(s):  
Salvatore Brugaletta ◽  
Josep Gomez-Lara ◽  
Roberto Diletti ◽  
Vasim Farooq ◽  
Robert Jan van Geuns ◽  
...  
Keyword(s):  
Metallic Stents ◽  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds

scholarly journals Effective decellularisation of human saphenous veins for biocompatible arterial tissue engineering applications: Bench optimisation and feasibility in vivo testing

2021 ◽  
Vol 12 ◽  
pp. 204173142098752
Author(s):  
Nadiah S Sulaiman ◽  
Andrew R Bond ◽  
Vito D Bruno ◽  
John Joseph ◽  
Jason L Johnson ◽  
...  
Keyword(s):  
Tissue Engineering ◽  
Mechanical Strength ◽  
Vascular Tissue ◽  
Sodium Dodecyl ◽  
Host Cells ◽  
Replacement Model ◽  
In Vivo Testing ◽  
Vascular Scaffolds

Human saphenous vein (hSV) and synthetic grafts are commonly used conduits in vascular grafting, despite high failure rates. Decellularising hSVs (D-hSVs) to produce vascular scaffolds might be an effective alternative. We assessed the effectiveness of a detergent-based method using 0% to 1% sodium dodecyl sulphate (SDS) to decellularise hSV. Decellularisation effectiveness was measured in vitro by nuclear counting, DNA content, residual cell viability, extracellular matrix integrity and mechanical strength. Cytotoxicity was assessed on human and porcine cells. The most effective SDS concentration was used to prepare D-hSV grafts that underwent preliminary in vivo testing using a porcine carotid artery replacement model. Effective decellularisation was achieved with 0.01% SDS, and D-hSVs were biocompatible after seeding. In vivo xeno-transplantation confirmed excellent mechanical strength and biocompatibility with recruitment of host cells without mechanical failure, and a 50% patency rate at 4-weeks. We have developed a simple biocompatible methodology to effectively decellularise hSVs. This could enhance vascular tissue engineering toward future clinical applications.

Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion

2015 ◽  
Vol 179 ◽  
pp. 90-94 ◽  
Author(s):  
Jens Wiebe ◽  
Christoph Liebetrau ◽  
Oliver Dörr ◽  
Astrid Most ◽  
Kay Weipert ◽  
...  
Keyword(s):  
Chronic Total Occlusion ◽  
Total Occlusion ◽  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds

scholarly journals Bioresorbable Vascular Scaffolds in Women

2017 ◽  
Vol 10 (18) ◽  
pp. 1891-1893 ◽  
Author(s):  
Gennaro Giustino ◽  
George D. Dangas
Keyword(s):  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds

scholarly journals TCT-57 Impact of Lesion Length on 1-year Outcomes of Absorb Bioresorbable Vascular Scaffolds

2016 ◽  
Vol 68 (18) ◽  
pp. B24
Author(s):  
Rony Lahoud ◽  
Stephen Ellis ◽  
Dean Kereiakes ◽  
Runlin Gao ◽  
Takeshi Kimura ◽  
...  
Keyword(s):  
Lesion Length ◽  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds
Sign in / Sign up

Export Citation Format

Share Document